Back
Protagonist Therapeutics Stock Price Chart
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
PTGX
Protagonist Therapeutics
Last Price:
$44.30
Seasonality Move:
34.62%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight buying pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.01 | Buy |
| 20-day SMA: | 44.95 | Buy |
| 50-day SMA: | 46.42 | Sell |
| 200-day SMA: | 42.76 | Buy |
| 8-day EMA: | 44.14 | Buy |
| 20-day EMA: | 44.67 | Buy |
| 50-day EMA: | 44.68 | Buy |
| 200-day EMA: | 41.11 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 51.27 | Buy |
| Chaikin Money Flow: | 461952 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.81 - 45.99) | Buy |
| Bollinger Bands (100): | (36.84 - 47.92) | Buy |
Protagonist Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 45.27 while PTGX 8-day simple moving average is 44.01, which is a Buy signal.
-
The stock price of PTGX is 45.27 while Protagonist Therapeutics 20-day SMA is 44.95, which makes it a Buy.
-
Protagonist Therapeutics 50-day simple moving average is 46.42 while PTGX share price is 45.27, making it a Sell technically.
-
PTGX stock price is 45.27 and Protagonist Therapeutics 200-day simple moving average is 42.76, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Buy
54
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a BuyThe current Protagonist Therapeutics [PTGX] share price is $45.27. The Score for PTGX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
2.8B
Price in USD:
45.27
Share Volume:
1M
Protagonist Therapeutics 52-Week Range
52-Week High:
60.60
52-Week Low:
27.00
Buy
54
Protagonist Therapeutics (PTGX)
is a Buy
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?The Protagonist Therapeutics stock price is 45.27 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is not overvalued.
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 45.27 while PTGX 8-day exponential moving average is 44.14, which is a Buy signal.
-
The stock price of PTGX is 45.27 while Protagonist Therapeutics 20-day EMA is 44.67, which makes it a Buy.
-
Protagonist Therapeutics 50-day exponential moving average is 44.68 while PTGX share price is 45.27, making it a Buy technically.
-
PTGX stock price is 45.27 and Protagonist Therapeutics 200-day simple moving average is 41.11, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.09 per share, a decrease this year of $4.05 per share, and an increase next year of $0.28 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is -0.51, suggesting Protagonist Therapeutics is a Sell
-
Protagonist Therapeutics Relative Strength Index (RSI) is 51.27, which suggest Protagonist Therapeutics is overbought
-
The Bollinger Bands (25) for Protagonist Therapeutics is (42.81 - 45.99), which suggest Protagonist Therapeutics is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics is (36.84 - 47.92), which suggest Protagonist Therapeutics is a Buy
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.